Globe Newswire

BERKELEY, Calif. and MAINZ, Germany, May 31, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, held its annual general meeting (“Annual General Meeting”) on Friday, May 31, 2024 in Amsterdam, The Netherlands. Holders of 2,431,947 ordinary shares, representing approximately 10.9% of our outstanding shares on May 3, 2024, the record date for the Annual General Meeting,... (continue reading...)

TORONTO, May 31, 2024 (GLOBE NEWSWIRE) -- Forge First Asset Management Inc., the manager of Forge First Long Short Alternative Fund and Forge First Conservative Alternative Fund (the “Funds”), announced that effective immediately, the investment strategies of the Funds have been amended as follows:

• Forge First Long Short Alternative Fund intends to maintain gross exposure at or around 200% (up from at or below 175%) with a range typically between 100% and 175%... (continue reading...)

CALGARY, Alberta, May 31, 2024 (GLOBE NEWSWIRE) -- FLINT Corp. (“FLINT” or the “Company”) (TSX: FLNT) today announced that it has extended the maturity dates of (i) its Asset-Based Revolving Credit Facility with The Toronto-Dominion Bank that provides for maximum borrowings of up to $50 million to April 14, 2027 (previously April 14, 2025), (ii) its Term Loan Facility with Canso Investment Counsel Ltd., in its capacity as portfolio manager for and on behalf... (continue reading...)

NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- Prospect Floating Rate and Alternative Income Fund, Inc. (“Prospect Floating Rate and Alternative Income Fund” or the “Fund”), announced today that the Fund’s Board of Directors has declared monthly cash common shareholder distributions for May 2024.

The annualized total cash distribution is $0.35625 per share (7.5% annualized percentage rate based on the net asset value as of March 31, 2024), for a distribution... (continue reading...)

HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced that today it closed on its Definitive Agreement to sell its Viactiv business to Doctor’s Best Inc. for gross cash... (continue reading...)